Dr. Swerdloff discusses the oral testosterone capsule Jatenzo
Ronald S. Swerdloff, MD, MACP, discusses the approved indication and efficacy of Jatenzo (testosterone undecanoate), an oral testosterone capsule. Jatenzo is approved by the FDA as a testosterone replacement therapy for men with certain forms of hypogonadism. It is indicated for patients with low testosterone levels as a results of certain medical conditions, such as genetic disorders or cancer-related damage to their pituitary gland.
Swerdloff is a senior investigator at the Lundquist Institute, chief, Division of Endocrinology, Harbor-UCLA Medical Center, and professor of Medicine, David Geffen School of Medicine at UCLA.
Study highlights how DTC online platforms often fail to convey risks of testosterone therapy
December 8th 2022“While there’s benefit in improving access, there’s also potential for harm when providers fail to follow evidence-based guidelines, or when the benefits and risks of treatment are not appropriately communicated," said Joshua A. Halpern, MD.
